Tome Biosciences
Watertown, United States· Est.
Tome Biosciences is a biotechnology company developing programmable genomic integration technologies for therapeutic applications.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $213M
About
Tome Biosciences is a biotechnology company developing programmable genomic integration technologies for therapeutic applications.
Gene TherapyCRISPRSynthetic Biology
Funding History
1Total raised:$213M
Venture$213M